ecrin-mdr-crcClinical2014metastatic unresectable colorectal cancer (mCRC) .Metastatic colorectal cancerMetastatic Colorectal CancerMetastatic Unresectable Colorectal Cancer (mcrc) .Interventionalhttps://newmdr.ecrin.org/Study/2532981Belgium11VECTIBIXAVASTINELOXATINADRUCILECRIN MDROngoingfalseA trial comparing 2 chemotherapies with personalized treatment with new drugs in patients with colorectal cancerPrimary objectives: - To assess Pogression Free Survival (PFS) of treatment Primary endpoints: Progression-free survival (PFS) rate at 1 years after randomisation2014-11-1525329812014-000543-33